Obermatt
See Similar Stocks →

Fortress Biotech

NAQ:FBIO · US34960Q3074
BiotechnologySmall

360

57
Medium confidence — indicative
Profit price—
Owner Earnings Yield98
Dividend Yield1
Price/Sales97
Price/Book87
Return on Capital78
Return on Equity98
EBIT Margin28
Gross Profitability62

Cash truth not applicable for financial companies.

Sales growth54
Profit growth6
Reinvestment42
Price momentum55
Debt load35
Debt serviceability3
Liquidity53
Analyst ratings100
Opinion Changes50
Price Target Upside100
Market mood3
Value Creation17/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Fortress Biotech generates returns well above its cost of capital, the foundation of durable shareholder value.

Based on 3/5 components.

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2006
Employees26
Websitefortressbiotech.com
ISINUS34960Q3074
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Infectious DiseasesDermatologyHematologyPain ManagementNeurologyImmunologyGenetic DisorderOncologyVaccinesBiotechnologyHealth CareLife SciencePharmaceutical

Description

Fortress Biotech, Inc. (Fortress) is a biopharmaceutical company. Fortress works in concert with its extensive network of key opinion leaders to identify and evaluate promising products and product candidates for potential acquisition. The company h…

Analysis

Middle-of-the-road

Fortress Biotech, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is solid; the safety picture is stretched. The company scores 17/20 on our value-creation score: strong value creator.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
31
2026

All-time high

34

Mar 2026

All-time low

31

Jun 2026

Average rank

33

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
97
—
—
—
Price/Earnings
74
—
—
—
Price/Book
87
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
92
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Fortress Biotech with its peers
Kalvista Pharmaceuticals
NMQ:KALV
60
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
PMV Pharmaceuticals
NSQ:PMVP
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Immix Biopharma
NAQ:IMMX
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Oric Pharmaceuticals
NSQ:ORIC
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Black Diamond Therapeutics
NSQ:BDTX
21
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Sagimet Biosciences
NMQ:SGMT
59
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →